This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Dental plaque and gingivitis are prevalent conditions that can be controlled using antimicrobial mouthwashes. AIM AND DESIGN: This double-blind, randomized controlled clinical trial aims to compare the effectiveness of 0.12% chlorhexidine (CHX) and silver nanoparticles (AgNPs) mouthwashes in managing dental plaque, gingivitis, microbial counts, and saliva pH. MATERIALS AND METHODS: A total of 95 medical students were randomly divided into three groups: Group I (control group), 0.9% sodium chloride; Group II, 0.12% CHX mouthwash; and Group III, AgNPs mouthwash. Clinical parameters evaluated on the baseline and 21stday included the gingival index, Quigley-Hein plaque index (QHI), microbial counts, and saliva pH. The analysis of variance (ANOVA), Tukey post-hoc test, and paired t-tests were implemented. RESULTS: The QHI in Group II decreased from 2.66 ± 0.75 to 1.97 ± 0.61 after 21 days (p < 0.001). Specifically for the QHI, there is a statistically significant difference between Group II and Group III, while there is no statistically significant difference when comparing the two groups in other clinical indices, and both groups showed a noticeable improvement after 21 days of use. CONCLUSIONS: Both 0.12% CHX and AgNPs mouthwashes are appropriate alternative options for daily oral hygiene. However, CHX mouthwash should still be prioritized for plaque control.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Thảo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: